Addictions
Accès gratuit
Numéro
Med Sci (Paris)
Volume 31, Numéro 8-9, Août–Septembre 2015
Addictions
Page(s) 784 - 791
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20153108018
Publié en ligne 4 septembre 2015
  1. Volkow ND, Wang GJ, Fowler JS, et al. Addiction: decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain’s control circuit. Bioessays 2010 ; 32 : 748–755. [CrossRef] [PubMed]
  2. Reuter J, Raedler T, Rose M, et al. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 2005 ; 8 : 147–148. [CrossRef] [PubMed]
  3. Clark L, Stokes PR, Wu K, et al. Striatal dopamine D2/D3 receptor binding in pathological gambling is correlated with mood-related impulsivity. Neuroimage 2012 ; 63 : 40–46. [CrossRef] [PubMed]
  4. Sescousse G, Barbalat G, Domenech P, Dreher JC. Imbalance in the sensitivity to different types of rewards in pathological gambling. Brain 2013 ; 136 : 2527–2538. [CrossRef] [PubMed]
  5. Chase HW, Clark L. Gambling severity predicts midbrain response to near-miss outcomes. J Neurosci 2010 ; 30 : 6180–6187. [CrossRef] [PubMed]
  6. De Ruiter MB, Veltman DJ, Goudriaan AE, et al. Response perseveration and ventral prefrontal sensitivity to reward and punishment in male problem gamblers and smokers. Neuropsychopharmacology 2009 ; 34 : 1027–1038. [CrossRef] [PubMed]
  7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th ed. Washington, DC : American Psychiatric Association, 2013.
  8. Welte JW, Barnes GM, Tidwell MC, et al. Gambling and problem gambling in the United States: changes between 1999 and 2013. J Gambl Stud 2014 ; doi : 10.1007/s10899-014-9471-4.
  9. Petry NM, Stinson FS, Grant BF. Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 2005 ; 66 : 564–574. [CrossRef] [PubMed]
  10. Goudriaan AE, Oosterlaan J, de Beurs E, Van den Brink W. Pathological gambling: a comprehensive review of biobehavioral findings. Neurosci Biobehav Rev 2004 ; 28 : 123–141. [CrossRef] [PubMed]
  11. Slutske WS, Eisen S, True WR, et al. Common genetic vulnerability for pathological gambling and alcohol dependence in men. Arch Gen Psychiatry 2000 ; 57 : 666–673. [CrossRef] [PubMed]
  12. Eisen SA, Slutskte WS, Lyons MJ, et al. The genetics of pathological gambling. Semin Clin Neuropsychiatry 2001 ; 6 : 195–204. [CrossRef] [PubMed]
  13. Volkow ND, Wang GJ, Fowler JS, et al. Addiction: beyond dopamine reward circuitry. Proc Natl Acad Sci USA 2011 ; 108 : 15037–15042. [CrossRef]
  14. Comings DE, Blum K. Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res 2000 ; 126 : 325–341. [CrossRef] [PubMed]
  15. Linnet J, Møller A, Peterson E, et al. Dopamine release in ventral striatum during Iowa gambling task performance is associated with increased excitement levels in pathological gambling. Addiction 2011 ; 106 : 383–390. [CrossRef] [PubMed]
  16. Joutsa J, Johansson J, Niemelä S, et al. Mesolimbic dopamine release is linked to symptom severity in pathological gambling. Neuroimage 2012 ; 60 : 1992–1999. [CrossRef] [PubMed]
  17. Boileau I, Payer D, Chugani B, et al. The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride. Addiction 2013 ; 108 : 953–963. [CrossRef] [PubMed]
  18. Boileau I, Payer D, Chugani B, et al. In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [11C]-(+)-PHNO. Mol Psychiatry 2014 ; 19 : 1305–1313. [CrossRef] [PubMed]
  19. Zack M, Poulos CX. Amphetamine primes motivation to gamble and gambling-related semantic networks in problem gamblers. Neuropsychopharmacology 2004 ; 29 : 195–207. [CrossRef] [PubMed]
  20. Zack M, Poulos CX. A D2 antagonist enhances the rewarding and priming effects of a gambling episode in pathological gamblers. Neuropsychopharmacology 2007 ; 32 : 1678–1686. [CrossRef] [PubMed]
  21. Clark L. Decision-making during gambling: an integration of cognitive and psychobiological approaches. Philos Trans R Soc Lond B Biol Sci 2010 ; 365 : 319–330. [CrossRef] [PubMed]
  22. Dodd ML, Klos KJ, Bower JH, et al. Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 2005 ; 62 : 1377–1381. [CrossRef] [PubMed]
  23. Weintraub D, Koester J, Potenza MN, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010 ; 67 : 589–595. [CrossRef] [PubMed]
  24. Dagher A, Robbins TW. Personality, addiction, dopamine: insights from Parkinson’s disease. Neuron 2009 ; 61 : 502–510. [CrossRef] [PubMed]
  25. Potenza MN. The neurobiology of pathological gambling and drug addiction: an overview and new findings. Philos Trans R Soc Lond B Biol Sci 2008 ; 363 : 3181–3189. [CrossRef] [PubMed]
  26. Grant JE, Kim SW, Hollander E, Potenza MN. Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacology 2008 ; 200 : 521–527. [CrossRef] [PubMed]
  27. Grant JE, Odlaug BL, Potenza MN, et al. Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study. Br J Psychiatry 2010 ; 197 : 330–331. [CrossRef] [PubMed]
  28. Leeman RF, Potenza MN. Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity. Psychopharmacology 2012 ; 219 : 469–490. [CrossRef] [PubMed]
  29. Grant JE, Chamberlain SR, Odlaug BL, et al. Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study. Psychopharmacology 2010 ; 212 : 603–612. [CrossRef] [PubMed]
  30. Grant JE, Kim SW, Odlaug BL. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol Psychiatry 2007 ; 62 : 652–657. [CrossRef] [PubMed]
  31. Kalivas PW. The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 2009 ; 10 : 561–572. [CrossRef] [PubMed]
  32. Van Holst RJ, van den Brink W, Veltman DJ, Goudriaan AE. Why gamblers fail to win: a review of cognitive and neuroimaging findings in pathological gambling. Neurosci Biobehav Rev 2010 ; 34 : 87–107. [CrossRef] [PubMed]
  33. Bechara A, Damasio AR, Damasio H, Anderson SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994 ; 50 : 7–15. [CrossRef] [PubMed]
  34. Cavedini P, Riboldi G, Keller R, et al. Frontal lobe dysfunction in pathological gambling patients. Biol Psychiatry 2002 ; 51 : 334–341. [CrossRef] [PubMed]
  35. Goudriaan AE, Oosterlaan J, de Beurs E, van den Brink W. Neurocognitive functions in pathological gambling: a comparison with alcohol dependence. Tourette syndrome and normal controls. Addiction 2006 ; 101 : 534–547.
  36. Roca M, Torralva T, López P, et al. Executive functions in pathologic gamblers selected in an ecologic setting. Cogn Behav Neurol 2008 ; 21 : 1–4. [CrossRef] [PubMed]
  37. Lakey CE, Goodie AS, Campbell WK. Frequent card playing and pathological gambling: the utility of the Georgia gambling task and Iowa gambling task for predicting pathology. J Gambl Stud 2007 ; 23 : 285–297. [CrossRef] [PubMed]
  38. Clark L, Cools R, Robbins TW. The neuropsychology of ventral prefrontal cortex: decision-making and reversal learning. Brain Cogn 2004 ; 55 : 41–53. [CrossRef] [PubMed]
  39. Brand M, Kalbe E, Labudda K, et al. Decision-making impairments in patients with pathological gambling. Psychiatry Res 2005 ; 133 : 91–99. [CrossRef] [PubMed]
  40. Lawrence AJ, Luty J, Bogdan NA, et al. Problem gamblers share deficits in impulsive decision-making with alcohol-dependent individuals. Addiction 2009 ; 104 : 1006–1015. [CrossRef] [PubMed]
  41. Miedl SF, Fehr T, Meyer G, Herrmann M. Neurobiological correlates of problem gambling in a quasi-realistic blackjack scenario as revealed by fMRI. Psychiatry Res 2010 ; 181 : 165–173. [CrossRef] [PubMed]
  42. Hewig J, Kretschmer N, Trippe RH, et al. Hypersensitivity to reward in problem gamblers. Biol Psychiatry 2010 ; 67 : 781–783. [CrossRef] [PubMed]
  43. Oberg SA, Christie GJ, Tata MS. Problem gamblers exhibit reward hypersensitivity in medial frontal cortex during gambling. Neuropsychologia 2011 ; 49 : 3768–3775. [CrossRef] [PubMed]
  44. Balodis IM, Kober H, Worhunsky PD, et al. Diminished frontostriatal activity during processing of monetary rewards and losses in pathological gambling. Biol Psychiatry 2012 ; 71 : 749–757. [CrossRef] [PubMed]
  45. Van Holst RJ, Veltman DJ, Büchel C, et al. Distorted expectancy coding in problem gambling: is the addictive in the anticipation? Biol Psychiatry 2012 ; 71 : 741–748. [CrossRef] [PubMed]
  46. Hommer DW, Bjork JM, Gilman JM. Imaging brain response to reward in addictive disorders. Ann NY Acad Sci 2011 ; 1216 : 50–61. [CrossRef]
  47. Leyton M, Vezina P. On cue: striatal ups and downs in addictions. Biol Psychiatry 2012 ; 72 : e21. [CrossRef] [PubMed]
  48. Schultz W. Multiple reward signals in the brain. Nat Rev Neurosci 2000 ; 1 : 199–207. [CrossRef] [PubMed]
  49. Voon V, Pessiglione M, Brezing C, et al. Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors. Neuron 2010 ; 65 : 135–142. [CrossRef] [PubMed]
  50. Clark L, Lawrence AJ, Astley-Jones F, Gray N. Gambling near-misses enhance motivation to gamble and recruit win-related brain circuitry. Neuron 2009 ; 61 : 481–490. [CrossRef] [PubMed]
  51. Potenza MN, Steinberg MA, Skudlarski P, et al. Gambling urges in pathological gambling: a functional magnetic resonance imaging study. Arch Gen Psychiatry 2003 ; 60 : 828–836. [CrossRef] [PubMed]
  52. Garavan H, Pankiewicz J, Bloom A, et al. Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry 2000 ; 157 : 1789–1798. [CrossRef] [PubMed]
  53. David SP, Munafò MR, Johansen-Berg H, et al. Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: a functional magnetic resonance imaging study. Biol Psychiatry 2005 ; 58 : 488–494. [CrossRef] [PubMed]
  54. Goudriaan AE, de Ruiter MB, van den Brink W, et al. Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study. Addict Biol 2010 ; 15 : 491–503. [CrossRef] [PubMed]
  55. Crockford DN, Goodtear B, Edwards J, et al. Cue-induced brain activity in pathological gamblers. Biol Psychiatry 2005 ; 58 : 787–795. [CrossRef] [PubMed]
  56. Power Y, Goodyear B, Crockford D. Neural correlates of pathological gamblers preference for immediate rewards during the Iowa gambling task: an fMRI study. J Gambl Stud 2012 ; 28 : 623–636. [CrossRef] [PubMed]
  57. Sescousse G, den Ouden HE. Gambling rats and gambling addiction: reconciling the role of dopamine in irrationality. J Neurosci 2013 ; 33 : 3256–3258. [CrossRef] [PubMed]
  58. Milosevic A, Ledgerwood DM. The subtyping of pathological gambling: a comprehensive review. Clin Psychol Rev 2010 ; 30 : 988–998. [CrossRef] [PubMed]
  59. Wilson SJ, Smyth JM, Maclean RR. Integrating ecological momentary assessment and functional brain imaging methods: new avenues for studying and treating tobacco dependence. Nicotine Tob Res 2013 ; 16 suppl 2 : S102–S110. [CrossRef] [PubMed]
  60. Ramoz N, Gorwood P. Les addictions sous l’angle de la génétique. Med Sci (Paris) 2015 ; 31 : 432–438. [CrossRef] [EDP Sciences] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.